LigaSure™ technology has been used in more than 4 million procedures worldwide.

There are well over 200 published peer-reviewed studies on LigaSure™ technology.

TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.

Valleylab™ mode is responsive energy that helps surgeons manage the tissue effect of surgical devices.

LigaSure™ technology can fuse vessels, including pulmonary vasculature*, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds* (*when used with the ForceTriad™ energy platform).

LigaSure™ Technology: Consistent, Reliable, Trusted Vessel Sealing

Since its introduction to the market in 1998, LigaSure™ technology has set the industry standard for vessel sealing. The technology has been used in more than 4 million procedures worldwide, and is supported by an ever-growing body of evidence-based research, now totaling well over 200 published peer-reviewed studies.

The clinical efficacy, consistency and reliability of LigaSure™ products is delivered through a variety of instruments for use in both laparoscopic and open procedures in a range of surgical specialties, including gynecological, colorectal, urology and general surgery.

Across the range of products and procedures, LigaSure™ technology delivers a unique combination of pressure and energy to create a consistent seal with each application.

• Provides a combination of pressure and energy to create vessel fusion
• Permanently fuses vessels up to and including 7 mm in diameter and tissue bundles without dissection or isolation
• Average seal cycle is 2 to 4 seconds*
• Seals withstand three times normal systolic blood pressure
• Feedback-controlled response system automatically discontinues energy delivery when the seal cycle is complete, eliminating the guesswork

* When used with ForceTriad™ energy platform